Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation

G. N. Barber, M. Wambach, S. Thompson, R. Jagus, M. G. Katze

Research output: Contribution to journalArticlepeer-review

136 Scopus citations

Fingerprint Dive into the research topics of 'Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation'. Together they form a unique fingerprint.

Medicine & Life Sciences